The Danish company’s drugs for obesity could have a profound impact on healthcare, society and our relationship with food
FT Person of the Year: Lars Fruergaard Jørgensen of Novo Nordisk
Recent Posts
- US targets UK, EU and Canada in new round of tariff probes
- US has burned through ‘years’ of munitions since start of Iran war
- US to ease Russian oil sanctions as energy prices soar
- Investors slash Fed rate-cut bets as Iran war sends petrol prices surging
- Fed to loosen capital requirements for big US banks
